PPT-PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
Author : ellena-manuel | Published Date : 2019-02-12
Program Overview Discussion Outline DNA Repair ABCs of DNA Repair DNA Repair Defects in Cancer DNA Repair Defects Can Be an Achilles Heel Synthetic Lethality and
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "PARP and Other DNA Damage Repair Inhibit..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update: Transcript
Program Overview Discussion Outline DNA Repair ABCs of DNA Repair DNA Repair Defects in Cancer DNA Repair Defects Can Be an Achilles Heel Synthetic Lethality and Cancer DNA Repair Defects Increased Sensitivity of . cellular sensing/responding, . and repair. Rebecca Fry, Ph.D.. DNA damage. DNA damage, due to environmental factors and normal metabolic processes inside the cell, occurs at a rate of 1,000 to 1,000,000 molecular lesions per cell per day. . DNA damage and repair and their role in carcinogenesis. A DNA sequence can be changed by copying errors introduced by DNA polymerase during replication and by environmental agents such as chemical mutagens or radiation. (. Danio. . rerio. ) . as a model. Chris A. . McCabe. 1. , Chris W. Theodorakis. 2. , Theodore B. Henry. 1. and Mark G. J. . Hartl. 1. Introduction . Environmental stressors can damage the DNA of aquatic organisms. and repair. Rebecca Fry, Ph.D.. DNA damage. DNA damage, due to environmental factors and normal metabolic processes inside the cell, occurs at a rate of 1,000 to 1,000,000 molecular lesions per cell per day. . and Opportunities. This program will include a discussion . of off-label treatment and investigational agents not approved by the FDA for use . in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. PARP Inhibitors: What Do We know?. PARP Inhibitors: What Do We Know? (cont). PARP Inhibitors: What Don't We Know ?. SOLO-1: Study Rationale and Design. [a]. Primary Endpoint and Other . R. esults. Time to Second Progression or Death (. Principles of Molecular Biology. Group Members. Maira Aleem. Bilal Naveed. Tanzeela Raza. Maheen. Malik. Zaigham. Abbas. DNA Structure. DNA = Deoxyribose nucleic . acid.. Four Nucleotides . - A. denine. actual. . video-recorded proceedings from the . live . CME event and may include the use of trade names and other raw, unedited content. . Mansoor Raza Mirza. NSGO: Nordic Society of Gynaecological Oncology. Five-year . survival. 15%. 30%. 40%. ?50%?. First use . of . cisplatin. First use . of . carboplatin. First use . of . Paclitaxel . First reports . of. bevacizumab. Positive evidence . for weekly paclitaxel in first line. CORE View metadata, citation and similar papers at core.ac.uk provided by University of Birmingham Research Portal Targeting DNA repair for anti-cancer therapy Thomas Helleday1,2,*, Cecilia Lundin, Be ABSTRACT Chemotherapy often targets dividing cells by causing DNA damage that leads to replication-dependent toxic lesions. Cells possess several overlapping DNA damage repair pathways that allow them REPLICATION ERRRORS AND THEIR REPAIR. The nature of mutations. Transitions. Transversions. Some replication errors escape proofreading. Mismatch repair removes errors that escape proofreading. Structure of . Latest developments. . Prof.. . Neeraj Agarwal, MD. Director, Genitourinary Oncology Program, . Huntsman Cancer Institute, University of Utah, USA. MARCH 2022. PARPi. , poly-ADP ribose polymerase inhibitors.
Download Document
Here is the link to download the presentation.
"PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents